Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable …PR Newswire (press release)Abbott's BVS delivers everolimus, an anti-proliferative drug. Everolimus is developed by Novartis Pharma AG and is licensed to Abbott by Novartis …
Pannus ExemptionsThedogs.com.auGreyhound Racing NSW advises participants that following extensive urine analyses performed after treatment of greyhounds affected by Pannus with Prednefrin Forte eye drops (prednisolone acetate ophthalmic suspension USP …
Very premature infants 'can benefit from corticosteroid use'International Federation of Gynecology and ObstetricsThe administration of corticosteroids in infants born at 23 to 25 weeks' gestation is associated with improved outcomes, new ma…
Family Practice News Digital NetworkSABCS: Addition of Everolimus Helps Slow Breast CancerMedPage TodayThis study found that the combination of the aromatase inhibitor exemestane (Aromasin) and everolimus (Afinitor) extends progression-free survival in…
UAB NewsAntenatal Corticosteroids Prevent Death in Premature InfantsMedscapeAccording to the researchers, current guidelines, published in 1995, recommend antenatal corticosteroids for mothers undergoing preterm labor at 24 to 34 weeks' gestational…
UAB NewsCorticosteroids boost survival of very premature infants, study findsMilwaukee Journal SentinelDoctors have known for years that giving corticosteroids to pregnant women at risk of delivering prematurely can accelerate lung development, but a n…
USA TodayNew drugs show promise for advanced breast cancerWashington Post (blog)In the second study, researchers gave 724 postmenopausal women whose tumors responded to the hormone estrogen either the drug exemestane, which is already used, plus a plac…
Benefit from Renal Cancer Drug Appears SmallMedPage Today… for advanced renal cell carcinoma — vascular endothelial growth factor (VEGF) receptor inhibitors sorafenib, sunitinib and pazopanib, and VEGF antibody bevacizumab; and mammalian target of r…
Loteprednol vs Prednisolone to Treat Intraocular Inflammation Following …Eye Doc NewsBausch & Lomb, Inc. is getting ready to launch a study that will evaluate the efficacy and safety of topical Loteprednol Etabonate (LE), 0.5%, to Prednisolone Ac…
Novartis to report cancer drug data at SABCS and ASH 2011ZenopaSABCS highlights will include phase III data on everolimus for advanced breast cancer, as well as further findings on Zometa and BKM120. Meanwhile, the ASH presentations will focus on appro…